India relies too heavily on screening for safe blood supply, conference toldBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7320.1024/c (Published 03 November 2001) Cite this as: BMJ 2001;323:1024
- Rohit Sharma
Despite mandatory screening, most of the blood being supplied in India continues to be unsafe, a conference on hepatitis C organised by Ranbaxy Science Foundation was told last week by a leading expert on blood transfusion.
“The changes that have been effected over the years have largely remained cosmetic,” said Dr Ambika Nanu, head of transfusion medicine at the All India Institute of Medical Sciences, New Delhi.
Screening of blood for HIV, hepatitis B and C, malaria, and syphilis was mandatory under Indian regulations, but this was not enough to guarantee safe supplies, she said.
Dr Nanu blamed the current policy of relying on screening alone to ensure a safe blood supply for the continuing crisis. The first steps to a safe blood transfusion …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial